This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Covisint Publishes Direct Messaging Toolkit For Healthcare, Clarifies Misconceptions And Outlines Benefits

Stock quotes in this article: CPWR

DETROIT, July 9, 2013 (GLOBE NEWSWIRE) -- Covisint, a Compuware (Nasdaq:CPWR) company, today announced that it has published a toolkit offering a comprehensive set of resources that outline the benefits of and uses for Direct messaging for key healthcare stakeholders. Collectively, these items answer common questions, dispel misconceptions and outline how Direct messaging makes healthcare providers eligible for federal monies and Meaningful Use Stage II requirements.

Compuware Logo
Covisint Logo

Specifically, the Covisint toolkit on Direct includes a:

  • whitepaper addressing whether Direct replaces HIEs, while also examining redundancies and HIPAA requirements ( The Direct Evolution; Why It Will Change How You Communicate);
  • guidebook on workflow integration and internal champions ( Steps to Direct Success); and,
  • research on why to adopt Direct ( Why You Need to Invest Today).

Direct messaging has received a large boost recently in two ways since it:

1. is federally driven -- the Office of the National Coordinator (ONC) and the Centers for Medicare and Medicaid (CMS) are increasingly requiring Direct to be part of the ecosystems of state Medicaid agencies and health information exchange (HIE) projects; and,

2. advances Meaningful Use Stage II qualification -- in order to continue receiving Meaningful Use funds and incentives, individual providers and hospitals are required to use a Direct solution.

"The momentum behind Direct is nearing the tipping point," said John Stanley, Principal, Impact Advisors. "Most healthcare providers and facilities are aware of Direct and are preparing a deployment plan."

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,723.50 -81.21 -0.48%
S&P 500 1,932.82 -13.34 -0.69%
NASDAQ 4,386.9370 -35.1480 -0.79%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs